Access the full text.
Sign up today, get DeepDyve free for 14 days.
S. Clifford, M. Cockman, A. Smallwood, D. Mole, E. Woodward, P. Maxwell, P. Ratcliffe, E. Maher (2001)
Contrasting effects on HIF-1alpha regulation by disease-causing pVHL mutations correlate with patterns of tumourigenesis in von Hippel-Lindau disease.Human molecular genetics, 10 10
Nan Tang, F. Mack, Volker Haase, M. Simon, Randall Johnson (2006)
pVHL Function Is Essential for Endothelial Extracellular Matrix DepositionMolecular and Cellular Biology, 26
A. Hergovich, J. Lisztwan, C. Thoma, C. Wirbelauer, R. Barry, W. Krek (2006)
Priming-Dependent Phosphorylation and Regulation of the Tumor Suppressor pVHL by Glycogen Synthase Kinase 3Molecular and Cellular Biology, 26
M. Landau, I. Mayrose, Yossi Rosenberg, F. Glaser, E. Martz, T. Pupko, N. Ben-Tal (2005)
ConSurf 2005: the projection of evolutionary conservation scores of residues on protein structuresNucleic Acids Research, 33
Reese (1997)
Improved splice site detection in GenieJ Comput Biol, 4
Mina Zhou, Hongmei Wang, J. Ross, I. Kuzmin, Chengen Xu, H. Cohen (2002)
The von Hippel-Lindau Tumor Suppressor Stabilizes Novel Plant Homeodomain Protein Jade-1*The Journal of Biological Chemistry, 277
E. Capriotti, P. Fariselli, I. Rossi, R. Casadio (2007)
A three-state prediction of single point mutations on protein stability changesBMC Bioinformatics, 9
(2009)
VHL mutations linked to type 2C von Hippel-Lindau 494
C. Béroud, D. Joly, C. Gallou, F. Staroz, M. Orfanelli, C. Junien (1998)
Software and database for the analysis of mutations in the VHL geneNucleic acids research, 26 1
C. Thoma, I. Frew, W. Krek (2007)
The VHL Tumor Suppressor: Riding Tandem with GSK3β in Primary Cilium MaintenanceCell Cycle, 6
Carles Ferrer-Costa, J. Gelpí, Leire Zamakola, Ivan Parraga, X. Cruz, M. Orozco (2005)
PMUT: a web-based tool for the annotation of pathological mutations on proteinsBioinformatics, 21 14
K. Ong, E. Woodward, Pip Killick, C. Lim, F. Macdonald, E. Maher (2004)
Genotype–phenotype correlations in von Hippel‐Lindau diseaseHuman Mutation, 28
M. Masso, I. Vaisman (2008)
Accurate prediction of stability changes in protein mutants by combining machine learning with structure based computational mutagenesisBioinformatics, 24 18
S. Richard (2011)
VHL (von Hippel-Lindau tumor suppressor)Atlas of genetics and cytogenetics in oncology and haematology
Julia Forman, C. Worth, G. Bickerton, Tim Eisen, Tom Blundell (2009)
Structural bioinformatics mutation analysis reveals genotype–phenotype correlations in von Hippel‐Lindau disease and suggests molecular mechanisms of tumorigenesisProteins: Structure, 77
M. Reese, F. Eeckman, D. Kulp, D. Haussler (1997)
Improved splice site detection in GenieJournal of computational biology : a journal of computational molecular cell biology, 4 3
Shuangye Yin, F. Ding, N. Dokholyan (2007)
Eris: an automated estimator of protein stabilityNature Methods, 4
E. Wagner, J. Lykke-Andersen (2002)
mRNA surveillance: the perfect persist.Journal of cell science, 115 Pt 15
C. Gallou, S. Longuemaux, C. Deloménie, A. Méjean, N. Martin, S. Martinet, G. Palais, R. Bouvier, D. Droz, R. Krishnamoorthy, C. Junien, C. Béroud, J. Dupret (2001)
Association of GSTT1 non-null and NAT1 slow/rapid genotypes with von Hippel-Lindau tumour suppressor gene transversions in sporadic renal cell carcinoma.Pharmacogenetics, 11 6
E. Leonardi, A. Murgia, Silvio Tosatto (2009)
Adding structural information to the von Hippel–Lindau (VHL) tumor suppressor interaction networkFEBS Letters, 583
Ingolf Sommer, Stefano Toppo, Oliver Sander, Thomas Lengauer, Silvio Tosatto (2006)
Improving the quality of protein structure models by selecting from alignment alternativesBMC Bioinformatics, 7
D. Spoel, E. Lindahl, B. Hess, G. Groenhof, A. Mark, H. Berendsen (2005)
GROMACS: Fast, flexible, and freeJournal of Computational Chemistry, 26
A. Bairoch, R. Apweiler, Cathy Wu, W. Barker, B. Boeckmann, Serenella Ferro, E. Gasteiger, Hongzhan Huang, R. Lopez, M. Magrane, M. Martin, D. Natale, C. O’Donovan, Nicole Redaschi, L. Yeh (2004)
The Universal Protein Resource (UniProt)Nucleic Acids Research, 33
Y. Guo, MC Schoell, R. Freeman (2009)
The von Hippel-Lindau protein sensitizes renal carcinoma cells to apoptotic stimuli through stabilization of BIMELOncogene, 28
Jin Liu, R. Nussinov (2008)
Allosteric effects in the marginally stable von Hippel–Lindau tumor suppressor protein and allostery-based rescue mutant designProceedings of the National Academy of Sciences, 105
Sofia Khan, M. Vihinen (2010)
Performance of protein stability predictorsHuman Mutation, 31
F. Turturro (2009)
Beyond the Knudson’s hypothesis in von Hippel–Lindau (VHL) disease—proposing vitronectin as a “gene modifier”Journal of Molecular Medicine, 87
Jae-seok Roe, Hyungsoo Kim, Soon‐Min Lee, Sung-Tae Kim, E. Cho, H. Youn (2006)
p53 stabilization and transactivation by a von Hippel-Lindau protein.Molecular cell, 22 3
Jing Zhang, L. Maquat (1997)
Evidence that translation reinitiation abrogates nonsense‐mediated mRNA decay in mammalian cellsThe EMBO Journal, 16
W. Kabsch, C. Sander (1983)
Dictionary of protein secondary structure: Pattern recognition of hydrogen‐bonded and geometrical featuresBiopolymers, 22
Michael Hoffman, M. Ohh, Haifeng Yang, J. Klco, Mircea Ivan, W. Kaelin, W. Kaelin (2001)
von Hippel-Lindau protein mutants linked to type 2C VHL disease preserve the ability to downregulate HIF.Human molecular genetics, 10 10
P. Corn, E. McDonald, J. Herman, W. El-Deiry (2003)
Tat-binding protein-1, a component of the 26S proteasome, contributes to the E3 ubiquitin ligase function of the von Hippel–Lindau proteinNature Genetics, 35
Jin Liu, R. Nussinov (2009)
The Mechanism of Ubiquitination in the Cullin-RING E3 Ligase Machinery: Conformational Control of Substrate OrientationPLoS Computational Biology, 5
Yigong Shi (2002)
Faculty Opinions recommendation of Structure of an HIF-1alpha -pVHL complex: hydroxyproline recognition in signaling.
Christopher Pettigrew, Melissa Brown (2008)
Pre-mRNA splicing aberrations and cancer.Frontiers in bioscience : a journal and virtual library, 13
A. Kuznetsova, J. Meller, P. Schnell, J. Nash, M. Ignacak, Y. Sánchez, J. Conaway, R. Conaway, M. Czyzyk-Krzeska (2003)
von Hippel–Lindau protein binds hyperphosphorylated large subunit of RNA polymerase II through a proline hydroxylation motif and targets it for ubiquitinationProceedings of the National Academy of Sciences of the United States of America, 100
X. Iturrioz, J. Durgan, V. Calleja, Banafshé Larijani, H. Okuda, Richard Whelan, P. Parker (2006)
The von Hippel–Lindau tumour-suppressor protein interaction with protein kinase CδBiochemical Journal, 397
(2006)
BMC Bioinformatics BioMed Central Database
Kaelin (2007)
Von Hippel-Lindau diseaseAnn Rev Pathol, 2
M. Martella, L. Salviati, A. Casarín, E. Trevisson, G. Opocher, R. Polli, D. Gross, A. Murgia (2006)
Molecular analysis of two uncharacterized sequence variants of the VHL geneJournal of Human Genetics, 51
M. Lolkema, D. Mans, C. Snijckers, M. Noort, M. Beest, E. Voest, R. Giles (2007)
The von Hippel–Lindau tumour suppressor interacts with microtubules through kinesin‐2FEBS Letters, 581
P. Bourne, K. Addess, Wolfgang Bluhm, Li Chen, Nita Deshpande, Zukang Feng, Ward Fleri, Rachel Green, Jeffrey Merino-Ott, Wayne Townsend-Merino, H. Weissig, J. Westbrook, H. Berman (2004)
The distribution and query systems of the RCSB Protein Data BankNucleic acids research, 32 Database issue
C. Lee, M. Hickey, C. Sanford, C. McGuire, C. Cowey, M. Simon, W. Rathmell (2009)
VHL Type 2B gene mutation moderates HIF dosage in vitro and in vivoOncogene, 28
A. Grosfeld, Ineke Stolze, M. Cockman, C. Pugh, Mariola Edelmann, B. Kessler, A. Bullock, P. Ratcliffe, N. Masson (2007)
Interaction of Hydroxylated Collagen IV with the von Hippel-Lindau Tumor Suppressor*Journal of Biological Chemistry, 282
P. Crossey, Charis Eng, Maria Ginalska-Malinowska, Thomas Lennard, Diana Wheeler, B. Ponder, Eamonn Maher (1995)
Molecular genetic diagnosis of von Hippel-Lindau disease in familial phaeochromocytoma.Journal of Medical Genetics, 32
(1991)
von Hippel-Lindau diseaseThe Lancet, 337
J. Lisztwan, G. Imbert, C. Wirbelauer, M. Gstaiger, W. Krek (1999)
The von Hippel-Lindau tumor suppressor protein is a component of an E3 ubiquitin-protein ligase activity.Genes & development, 13 14
Min (2002)
Structure of an HIF-1alpha -pVHL complex: Hydroxyproline recognition in signalingScience, 296
J. Thusberg, M. Vihinen (2009)
Pathogenic or not? And if so, then how? Studying the effects of missense mutations using bioinformatics methodsHuman Mutation, 30
T. Kamura, K. Maenaka, Shuhei Kotoshiba, M. Matsumoto, D. Kohda, R. Conaway, J. Conaway, K. Nakayama (2004)
VHL-box and SOCS-box domains determine binding specificity for Cul2-Rbx1 and Cul5-Rbx2 modules of ubiquitin ligases.Genes & development, 18 24
Eszter Nagy, L. Maquat (1998)
A rule for termination-codon position within intron-containing genes: when nonsense affects RNA abundance.Trends in biochemical sciences, 23 6
Y. Bromberg, B. Rost (2007)
SNAP: predict effect of non-synonymous polymorphisms on functionNucleic Acids Research, 35
W. Kaelin (2008)
The von Hippel–Lindau tumour suppressor protein: O2 sensing and cancerNature Reviews Cancer, 8
P. Stenson, E. Ball, M. Mort, A. Phillips, Jacqueline Shiel, N. Thomas, S. Abeysinghe, M. Krawczak, D. Cooper (2003)
Human Gene Mutation Database (HGMD®): 2003 updateHuman Mutation, 21
G. Franke, B. Bausch, M. Hoffmann, M. Cybulla, C. Wilhelm, J. Kohlhase, G. Scherer, H. Neumann (2009)
Alu‐Alu recombination underlies the vast majority of large VHL germline deletions: Molecular characterization and genotype–phenotype correlations in VHL patientsHuman Mutation, 30
I. Kuzmin, F. Duh, F. Latif, L. Geil, Berton Zbar, M. Lerman (1995)
Identification of the promoter of the human von Hippel-Lindau disease tumor suppressor gene.Oncogene, 10 11
雅州 坂口, 修 阿部, 悠介 戸田, 裕子 大森, ミキ 星野, 航 佐瀬, 崇裕 上條, 拓也 相澤, 崇 雫石, 潤子 菊田, 生恵 田中, 俊也 前林, 矢野 希世志, 弘樹 原留, 克己 阿部 (2012)
[Von Hippel-Lindau disease].Journal Francais D Ophtalmologie, 71
K. Kondo, W. Kaelin (2001)
The von Hippel-Lindau tumor suppressor gene.Experimental cell research, 264 1
Jae-seok Roe, H. Youn (2006)
The Positive Regulation of p53 by the Tumor Suppressor VHLCell Cycle, 5
D. Chauveau, C. Burcklé, C. Béroud, J. Correas, J. Duclos, P. Michel, S. Richard, J. Grünfeld (2002)
Diagnosis of pheochromocytoma and laparoscopic adrenalectomy in two anephric patients with von Hippel-Lindau disease.American journal of kidney diseases : the official journal of the National Kidney Foundation, 39 2
X. Iturrioz, J. Durgan, V. Calleja, Banafshé Larijani, H. Okuda, Richard Whelan, P. Parker (2006)
The von Hippel-Lindau tumour-suppressor protein interaction with protein kinase Cdelta.The Biochemical journal, 397 1
M. Ritter, A. Frilling, P. Crossey, W. Höppner, Eamonn Maher, L. Mulligan, B. Ponder, D. Engelhardt (1996)
Isolated familial pheochromocytoma as a variant of von Hippel-Lindau disease.The Journal of clinical endocrinology and metabolism, 81 3
Paul A.Crossey, Frances M.Richards, K. Foster, Jane reen, A. Prowse, Farida Latlf, M. Lerman, B. Zbar, Nabeel Atfara, M. Ferguson-Smith, E. Maher (1994)
Identification of intragenic mutations in the von Hippel-Lindau disease tumour suppressor gene and correlation with disease phenotype.Human molecular genetics, 3 8
J. Thompson, D. Higgins, T. Gibson (1994)
CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice.Nucleic acids research, 22 22
S. Altschul, Thomas Madden, A. Schäffer, Jinghui Zhang, Zheng Zhang, W. Miller, D. Lipman (1997)
Gapped BLAST and PSI-BLAST: a new generation of protein database search programs.Nucleic acids research, 25 17
Sutovsky (2004)
The von Hippel-Lindau tumor suppressor protein is a molten globule under native conditions: Implications for its physiological activitiesJ Biol Chem, 279
A. Casarín, M. Martella, R. Polli, E. Leonardi, Laura Anesi, A. Murgia (2006)
Molecular Characterization of Large Deletions in the von Hippel-Lindau (VHL) Gene by Quantitative Real-Time PCRMolecular Diagnosis & Therapy, 10
K. Knauth, C. Bex, P. Jemth, A. Buchberger (2006)
Renal cell carcinoma risk in type 2 von Hippel-Lindau disease correlates with defects in pVHL stability and HIF-1alpha interactions.Oncogene, 25 3
Ritter (1996)
Isolated familial pheochromocytoma as a variant of von Hippel-Lindau diseaseJ Clin Endocrinol Metab, 81
Morgan Nordstrom-O'Brien, R. Luijt, E. Rooijen, A. Ouweland, D. Majoor-Krakauer, M. Lolkema, Aram Brussel, E. Voest, R. Giles (2010)
Genetic analysis of von Hippel‐Lindau diseaseHuman Mutation, 31
K. Knauth, E. Cartwright, S. Freund, M. Bycroft, A. Buchberger (2009)
VHL Mutations Linked to Type 2C von Hippel-Lindau Disease Cause Extensive Structural Perturbations in pVHL*Journal of Biological Chemistry, 284
M. Abbott, K. Nathanson, S. Nightingale, E. Maher, R. Greenstein (2006)
The von Hippel–Lindau (VHL) germline mutation V84L manifests as early‐onset bilateral pheochromocytomaAmerican Journal of Medical Genetics Part A, 140A
Sungwoo Lee, E. Nakamura, Haifeng Yang, Wenyi Wei, Michelle Linggi, M. Sajan, R. Farese, R. Freeman, B. Carter, W. Kaelin, S. Schlisio (2005)
Neuronal apoptosis linked to EglN3 prolyl hydroxylase and familial pheochromocytoma genes: developmental culling and cancer.Cancer cell, 8 2
F. Hes, R. Luijt, A. Janssen, RA Zewald, G. Jong, JW Lenders, T. Links, G. Luyten, R. Sijmons, H. Eussen, D. Halley, C. Lips, P. Pearson, A. Ouweland, D. Majoor-Krakauer (2007)
Frequency of Von Hippel‐Lindau germline mutations in classic and non‐classic Von Hippel‐Lindau disease identified by DNA sequencing, Southern blot analysis and multiplex ligation‐dependent probe amplificationClinical Genetics, 72
W. Kaelin, E. Maher (1998)
The VHL tumour-suppressor gene paradigm.Trends in genetics : TIG, 14 10
M. Ohh, R. Yauch, K. Lonergan, J. Whaley, A. Stemmer-Rachamimov, D. Louis, B. Gavin, N. Kley, W. Kaelin, W. Kaelin, O. Iliopoulos (1998)
The von Hippel-Lindau tumor suppressor protein is required for proper assembly of an extracellular fibronectin matrix.Molecular cell, 1 7
V. Ramensky, P. Bork, S. Sunyaev (2002)
Human non-synonymous SNPs: server and survey.Nucleic acids research, 30 17
Yue (2006)
SNPs3D: Candidate gene and SNP selection for association studiesBMC Bioinformatics, 7
Stefan Hebsgaard, Peter Korning, N. Tolstrup, J. Engelbrecht, P. Rouzé, S. Brunak (1996)
Splice site prediction in Arabidopsis thaliana pre-mRNA by combining local and global sequence information.Nucleic acids research, 24 17
P. Gouet, E. Courcelle, D. Stuart, F. Metoz (1999)
ESPript: analysis of multiple sequence alignments in PostScriptBioinformatics, 15 4
Mutational inactivation of the VHL gene is the cause of von Hippel‐Lindau (VHL) disease, an autosomal dominant hereditary cancer syndrome predisposing to haemangioblastomas, pheochromocytomas and clear‐cell renal carcinomas. The gene product (pVHL) functions as an adapter in cellular processes including cell growth and apoptosis. VHL mutation analysis was carried out in 426 unrelated subjects with phenotypes ranging from VHL syndrome, to isolated VHL‐related tumours that could represent the first manifestation of the disease. A total of 111 individuals were found to carry alterations, with large deletions representing 40% of the variants. Eighteen of the 95 detected variants were novel, seemingly disease‐causing mutations; their pathogenic role has been evaluated in silico for effects on protein folding and interactions. Putative regions of interaction between pVHL and proteins involved in common pathways have been identified, assessing possible implications for the presence of mutations in these regions. All new variants predicted to truncate or cause complete pVHL loss of structure were associated with phenotypes consistent with VHL type 1. Seven of the new amino acid substitutions are disease‐causing mutations, one is a neutral variant, whereas the results for two remain ambiguous. Our combined molecular and in silico approach for the evaluation of putative disease‐causing mutations contributes to the interpretation of the potential pathogenicity of these novel variants.
Annals of Human Genetics – Wiley
Published: Jan 1, 2011
Keywords: ; ; ; ;
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.